Cite

HARVARD Citation

    Shen, L. et al. (n.d.). 65PA novel recombinant human anti-PD-1 monoclonal antibody GLS-010 in patients with advanced cancer: Result of a phase Ia clinical trial. Annals of oncology. p. . [Online]. 
  
Back to record